EdgarLookup

FIRST BANCORP /NC/ — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that FIRST BANCORP /NC/ filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
164.2%
Profit Margin
Net income ÷ revenue
0.9%
Return on Assets
Net income ÷ assets
6.66x
Debt-to-Equity
Total liabilities ÷ equity
-3.6%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $67.62M Feb 25, 2026
FY2025 Dec 31, 2024 $70.12M Feb 25, 2026
FY2025 Dec 31, 2023 $32.82M Feb 25, 2026
FY2024 Dec 31, 2022 $17.45M Feb 26, 2025
FY2023 Dec 31, 2021 $25.32M Feb 28, 2024

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $111.05M Feb 25, 2026
FY2025 Dec 31, 2024 $76.22M Feb 25, 2026
FY2025 Dec 31, 2023 $104.13M Feb 25, 2026
FY2024 Dec 31, 2022 $146.94M Feb 26, 2025
FY2023 Dec 31, 2021 $95.64M Feb 28, 2024
FY2022 Dec 31, 2020 $81.48M Feb 28, 2023
FY2021 Dec 31, 2019 $92.05M Mar 1, 2022
FY2020 Dec 31, 2018 $89.29M Feb 26, 2021
FY2019 Dec 31, 2017 $45.97M Feb 28, 2020
FY2018 Dec 31, 2016 $27.51M Mar 1, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $203.13M Feb 25, 2026
FY2025 Dec 31, 2024 $174.78M Feb 25, 2026
FY2025 Dec 31, 2023 $131.40M Feb 25, 2026
FY2024 Dec 31, 2022 $230.65M Feb 26, 2025
FY2023 Dec 31, 2021 $142.34M Feb 28, 2024
FY2022 Dec 31, 2020 $58.33M Feb 28, 2023
FY2021 Dec 31, 2019 $51.24M Mar 1, 2022
FY2020 Dec 31, 2018 $46.41M Feb 26, 2021
FY2019 Dec 31, 2017 $26.84M Feb 28, 2020
FY2018 Dec 31, 2016 $41.27M Mar 1, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.25M Feb 25, 2026
FY2025 Dec 31, 2024 $2.66M Feb 25, 2026
FY2025 Dec 31, 2023 $4.42M Feb 25, 2026
FY2024 Dec 31, 2022 $5.29M Feb 26, 2025
FY2023 Dec 31, 2021 $9.40M Feb 28, 2024
FY2022 Dec 31, 2020 $12.36M Feb 28, 2023
FY2021 Dec 31, 2019 $3.53M Mar 1, 2022
FY2020 Dec 31, 2018 $10.72M Feb 26, 2021
FY2019 Dec 31, 2017 $4.66M Feb 28, 2020
FY2018 Dec 31, 2016 $8.69M Mar 1, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $12.67B Feb 25, 2026
FY2025 Dec 31, 2024 $12.15B Feb 25, 2026
FY2024 Dec 31, 2023 $12.11B Feb 26, 2025
FY2023 Dec 31, 2022 $10.63B Feb 28, 2024
FY2022 Dec 31, 2021 $10.51B Feb 28, 2023
FY2021 Dec 31, 2020 $7.29B Mar 1, 2022
FY2020 Dec 31, 2019 $6.14B Feb 26, 2021
FY2019 Dec 31, 2018 $5.86B Feb 28, 2020
FY2018 Dec 31, 2017 $5.55B Mar 1, 2019
FY2017 Dec 31, 2016 $3.61B Mar 1, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $11.01B Feb 25, 2026
FY2025 Dec 31, 2024 $10.70B Feb 25, 2026
FY2024 Dec 31, 2023 $10.74B Feb 26, 2025
FY2023 Dec 31, 2022 $9.59B Feb 28, 2024
FY2022 Dec 31, 2021 $9.28B Feb 28, 2023
FY2021 Dec 31, 2020 $6.40B Mar 1, 2022
FY2020 Dec 31, 2019 $5.29B Feb 26, 2021
FY2019 Dec 31, 2018 $5.10B Feb 28, 2020
FY2018 Dec 31, 2017 $4.85B Mar 1, 2019
FY2017 Dec 31, 2016 $3.25B Mar 1, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.65B Feb 25, 2026
FY2025 Dec 31, 2024 $1.45B Feb 25, 2026
FY2025 Dec 31, 2023 $1.37B Feb 25, 2026
FY2025 Dec 31, 2022 $1.03B Feb 25, 2026
FY2024 Dec 31, 2021 $1.23B Feb 26, 2025
FY2023 Dec 31, 2020 $893.42M Feb 28, 2024
FY2022 Dec 31, 2019 $852.40M Feb 28, 2023
FY2021 Dec 31, 2018 $764.23M Mar 1, 2022
FY2020 Dec 31, 2017 $692.98M Feb 26, 2021
FY2019 Dec 31, 2016 $368.10M Feb 28, 2020

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $478.75M Feb 25, 2026
FY2025 Dec 31, 2024 $478.75M Feb 25, 2026
FY2024 Dec 31, 2023 $478.75M Feb 26, 2025
FY2024 Dec 31, 2022 $364.26M Feb 26, 2025
FY2023 Dec 31, 2021 $364.26M Feb 28, 2024
FY2022 Dec 31, 2020 $239.27M Feb 28, 2023
FY2021 Dec 31, 2019 $234.37M Mar 1, 2022
FY2019 Dec 31, 2018 $234.37M Feb 28, 2020
FY2018 Dec 31, 2017 $233.07M Mar 1, 2019
FY2017 Dec 31, 2016 $75.04M Mar 1, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $829.66M Feb 25, 2026
FY2025 Dec 31, 2024 $756.33M Feb 25, 2026
FY2024 Dec 31, 2023 $716.42M Feb 26, 2025
FY2023 Dec 31, 2022 $648.42M Feb 28, 2024
FY2022 Dec 31, 2021 $532.87M Feb 28, 2023
FY2021 Dec 31, 2020 $478.49M Mar 1, 2022
FY2020 Dec 31, 2019 $417.76M Feb 26, 2021
FY2019 Dec 31, 2018 $341.74M Feb 28, 2020
FY2018 Dec 31, 2017 $264.33M Mar 1, 2019
FY2017 Dec 31, 2016 $225.92M Mar 1, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2018 Dec 31, 2018 $462.90M Mar 1, 2019
FY2018 Dec 31, 2017 $489.49M Mar 1, 2019
FY2018 Dec 31, 2016 $305.99M Mar 1, 2019
FY2018 Dec 31, 2015 $267.27M Mar 1, 2019
FY2017 Dec 31, 2014 $253.08M Mar 1, 2018
FY2016 Dec 31, 2013 $223.27M Mar 15, 2017
FY2015 Dec 31, 2012 $241.51M Mar 14, 2016
FY2014 Dec 31, 2011 $216.17M Mar 13, 2015
FY2013 Dec 31, 2010 $212.00M Mar 17, 2014
FY2012 Dec 31, 2009 $350.87M Mar 15, 2013

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $74.57M Feb 25, 2026
FY2025 Dec 31, 2024 $91.88M Feb 25, 2026
FY2024 Dec 31, 2023 $630.16M Feb 26, 2025
FY2023 Dec 31, 2022 $287.51M Feb 28, 2024
FY2022 Dec 31, 2021 $67.39M Feb 28, 2023
FY2021 Dec 31, 2020 $61.83M Mar 1, 2022
FY2020 Dec 31, 2019 $300.67M Feb 26, 2021
FY2019 Dec 31, 2018 $406.61M Feb 28, 2020
FY2018 Dec 31, 2017 $410.67M Mar 1, 2019
FY2012 Dec 31, 2012 $46.39M Mar 15, 2013

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 2 Feb 25, 2026
FY2025 Dec 31, 2024 1 Feb 25, 2026
FY2025 Dec 31, 2023 2 Feb 25, 2026
FY2024 Dec 31, 2022 4 Feb 26, 2025
FY2023 Dec 31, 2021 3 Feb 28, 2024
FY2022 Dec 31, 2020 2 Feb 28, 2023
FY2021 Dec 31, 2019 3 Mar 1, 2022
FY2020 Dec 31, 2018 3 Feb 26, 2021
FY2019 Dec 31, 2017 1 Feb 28, 2020
FY2018 Dec 31, 2016 1 Mar 1, 2019

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 2 Feb 25, 2026
FY2025 Dec 31, 2024 1 Feb 25, 2026
FY2025 Dec 31, 2023 2 Feb 25, 2026
FY2024 Dec 31, 2022 4 Feb 26, 2025
FY2023 Dec 31, 2021 3 Feb 28, 2024
FY2022 Dec 31, 2020 2 Feb 28, 2023
FY2021 Dec 31, 2019 3 Mar 1, 2022
FY2020 Dec 31, 2018 3 Feb 26, 2021
FY2019 Dec 31, 2017 1 Feb 28, 2020
FY2018 Dec 31, 2016 1 Mar 1, 2019

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 41.47M Feb 25, 2026
FY2025 Dec 31, 2024 41.35M Feb 25, 2026
FY2024 Dec 31, 2023 41.11M Feb 26, 2025
FY2023 Dec 31, 2022 35.70M Feb 28, 2024
FY2022 Dec 31, 2021 35.63M Feb 28, 2023
FY2021 Dec 31, 2020 28.58M Mar 1, 2022
FY2020 Dec 31, 2019 29.60M Feb 26, 2021
FY2019 Dec 31, 2018 29.72M Feb 28, 2020
FY2018 Dec 31, 2017 29.64M Mar 1, 2019
FY2018 Dec 31, 2016 20.84M Mar 1, 2019

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $37.28M Feb 25, 2026
FY2025 Dec 31, 2024 $36.25M Feb 25, 2026
FY2025 Dec 31, 2023 $34.94M Feb 25, 2026
FY2024 Dec 31, 2022 $30.66M Feb 26, 2025
FY2023 Dec 31, 2021 $22.23M Feb 28, 2024
FY2022 Dec 31, 2020 $20.94M Feb 28, 2023
FY2021 Dec 31, 2019 $13.66M Mar 1, 2022
FY2020 Dec 31, 2018 $11.28M Feb 26, 2021
FY2019 Dec 31, 2017 $7.60M Feb 28, 2020
FY2018 Dec 31, 2016 $6.40M Mar 1, 2019